Cervical dysplasia: tests, grades and treatment

Cervical dysplasia is an abnormal change in cells on the surface of the cervix, usually linked to persistent HPV infection.

It is also called cervical intraepithelial neoplasia, or CIN. These changes are not cervical cancer, but some higher-grade abnormalities may develop further if they are not monitored or treated. Screening allows changes to be found before they become invasive.

Cervical dysplasia usually causes no symptoms and is commonly detected through cervical screening. Cervical disease can present with bleeding after sex or bleeding between periods, but these symptoms have many possible causes and do not show whether dysplasia is present.

Arrange a clinical assessment for unexplained bleeding rather than waiting for a routine screening appointment. Seek urgent care if bleeding is heavy, you feel faint, or pain is severe or rapidly worsening.

Persistent infection with a high-risk type of human papillomavirus can alter cervical cells over time. HPV spreads through intimate skin-to-skin contact and is very common; infection does not imply infidelity. The immune system often clears or suppresses HPV, but cell changes can develop when a high-risk infection persists.

Low-grade changes may return to normal as HPV is controlled by the immune system. Higher-grade changes are less likely to settle without intervention and are more often removed. The grade describes how abnormal the sampled cells look and helps determine monitoring or treatment; it is not a cancer stage.

Smoking can weaken local immune control of HPV. A weakened immune system, including from immune-suppressing treatment or certain health conditions, can also make persistent infection and cell changes more likely. Missing cervical screening can delay detection but does not itself cause dysplasia.

Cervical screening may test for high-risk HPV and examine cells for abnormalities. An HPV-positive or abnormal result may lead to repeat testing or colposcopy, depending on the finding. During colposcopy, a clinician views the cervix under magnification and may take a small biopsy.

The laboratory report confirms whether dysplasia is present and describes its grade. An abnormal screening test is therefore a signal for assessment, not a diagnosis of cancer.

Low-grade changes may be monitored with scheduled HPV testing, cervical sampling or colposcopy. For higher-grade changes, loop excision of the cervix removes the affected transformation zone using a fine heated wire. A cone biopsy removes a cone-shaped piece of cervical tissue and may be used when the abnormal area extends into the cervical canal or more tissue is needed.

The clinician should explain discomfort control, bleeding or discharge during recovery, possible effects on future pregnancy and the follow-up plan before treatment. Heavy bleeding, fever, foul-smelling discharge or worsening pelvic pain after a procedure needs prompt medical advice.

An abnormal result can create anxiety even though dysplasia is not cancer. Write down the exact result, whether a biopsy confirmed it, and the date of the next appointment. Ask what activities to avoid after biopsy or treatment, and use reliable contraception during recovery if advised.

Untreated high-grade dysplasia can progress towards cervical cancer, although progression is not inevitable. Excisional treatment can cause bleeding, infection or narrowing of the cervix, and removing cervical tissue may affect later pregnancy care. Decisions balance the grade and location of changes with age, pregnancy wishes and prior treatment.

HPV vaccination reduces the chance of infection from covered high-risk types but does not replace cervical screening. Attending screening and follow-up helps detect changes early. Stopping smoking supports the immune response to HPV, while barrier methods can reduce but cannot eliminate HPV transmission because uncovered skin can carry the virus.

A colposcopy clinic or gynaecologist assesses abnormal cervical results and plans treatment. Ask whether the clinic offers the recommended procedure, how tissue is examined and who will communicate the result. If future pregnancy is important, discuss this before excisional treatment so the plan can account for both safety and fertility goals.